Details of the Drug Combinations

General Information of This Drug (ID: DMM58JY)

Drug Name

Ziprasidone DMM58JY

Synonyms

146939-27-7; Geodon; Zeldox; Ziprasidone hydrochloride; Ziprasidone [INN:BAN]; UNII-6UKA5VEJ6X; CP 88059; Ziprasidone mesylate trihydrate; 6UKA5VEJ6X; CHEMBL708; C21H21ClN4OS; CHEBI:10119; CP-88,059-1; ziprazidone; DSSTox_CID_3753; DSSTox_RID_77186; 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one; DSSTox_GSID_23753; ziprasidonum; ziprasidona; 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one; Geodon; Zipradon; Ziprasidona; Ziprasidonum; Ziprazidone; CP 88059-01; Geodon (TN); Zeldox (TN); Zipradon (TN); Ziprasidone (INN); CP-88,059; CP-88059-1; CP-88,059-01; 5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one; 5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one; 6-chloro-5-[2-[4-(7-thia-8-azabicyclo[430]nona-1,3,5,8-tetraen-9-yl)piperazin-1-yl]ethyl]-1,3-dihydroindol-2-one; TC-5280

Indication

Disease Entry	ICD 11	Status	REF
Bipolar disorder	6A60	Approved	[1]
Schizoaffective disorder	6A21	Approved	[1]
Schizophrenia	6A20	Approved	[2]
------------------------------------------------------------------------------------

Therapeutic Class

Antipsychotic Agents

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

4 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Sertraline + Ziprasidone	DCWOLJK	Sertraline	Social Anxiety Disorder	[3]
Ziprasidone + Olanzapine	DCFLM1J	Olanzapine	Schizophrenia	[4]
Ziprasidone + Olanzapine	DCW7IXX	Olanzapine	Hyperglycemia	[5]
Ziprasidone + Oxycodone	DCHXEDU	Oxycodone	Addiction	[6]
------------------------------------------------------------------------------------

References

1	Ziprasidone FDA Label
2	The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22.
3	ClinicalTrials.gov (NCT00215150) Geodon for the Treatment of Refractory Social Anxiety Disorder
4	ClinicalTrials.gov (NCT01185743) Antipsychotics and Gene Expression in Soft Tissues
5	ClinicalTrials.gov (NCT00910988) Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone
6	ClinicalTrials.gov (NCT04587115) Reducing the Abuse Liability of Prescription Opioids